companydata.dkcompanydata.dk

ORIFARM GENERICS HOLDING A/S: Financial statements 2019

CVR: 27347223

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2019. In 2019, the company reported a gross profit of EUR 1,684,000 and a net result of EUR 9,696,000 compared with EUR 5,504,000 the year before. That is an increase of 99.1% compared with the year before. Equity in the 2019 report amounted to EUR 40,599,000. The solvency ratio was 58.9%. The company had 204 employees in the financial year.

Revenue
EUR 0
Gross Profit
EUR 1,684,000
Profit/Loss
EUR 9,696,000
Equity
EUR 40,599,000
Total Assets
EUR 68,909,000
Employees
204

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20190 EUR1.7M EUR9.7M EUR40.6M EUR204
2018-846K EUR5.5M EUR35.9M EUR203
2017-701K EUR8.5M EUR38.5M EUR188
2016-1M EUR9M EUR35M EUR165
2015-5.7M5.2M194.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Ulrik Kronborg Markussen joins ORIFARM GENERICS HOLDING A/S as adm. dir.Aug 26, 2019

As of August 26, 2019, Ulrik Kronborg Markussen is registered as adm. dir. of ORIFARM GENERICS HOLDING A/S.

Karsten Haumann steps down as adm. dir. of ORIFARM GENERICS HOLDING A/SAug 26, 2019

As of August 26, 2019, Karsten Haumann has stepped down as adm. dir. of ORIFARM GENERICS HOLDING A/S.

ORIFARM GENERICS HOLDING A/S: The 2018 annual report is outMay 31, 2019

ORIFARM GENERICS HOLDING A/S has published its annual report for 2018. Gross profit came to DKK 846,000, and the net result was DKK 5,504,000.

About ORIFARM GENERICS HOLDING A/S

ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.

Source: annual report 2025, Danish Business Authority